Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tolerability of Transcutaneous Vagal Nerve Stimulation

NCT: NCT07735234 · NOT_YET_RECRUITING

NCT IDNCT07735234
StatusNOT_YET_RECRUITING
Start Date2026-07-30
Completion2026-09-04
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.

Frequently Asked Questions

What is Tolerability of Transcutaneous Vagal Nerve Stimulation?

Tolerability of Transcutaneous Vagal Nerve Stimulation is a clinical trial registered under NCT07735234. Current status: NOT_YET_RECRUITING.

What is the status of NCT07735234?

The current status of NCT07735234 (Tolerability of Transcutaneous Vagal Nerve Stimulation) is: NOT_YET_RECRUITING.

When did Tolerability of Transcutaneous Vagal Nerve Stimulation start?

Tolerability of Transcutaneous Vagal Nerve Stimulation started on 2026-07-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.